Almeda Ventures Valuation Multiples

Almeda Ventures is valued at $15M as of October 2026.

Almeda Ventures Overview

About Almeda Ventures

Almeda Ventures LP is a life science research and development company. The company invests in Medical devices and Digital health businesses. Its portfolio includes BioProtect, which developed a proprietary technology platform for biodegradable balloons. The technology suits a range of clinical applications, including spacing for radiation oncology protection and general surgery. TailorMed technology improves the financial performance of healthcare providers and reduces financial hardship for patients.


Founded

2020

HQ

Israel

Employees

110

Sectors

Financials (Last FY)

Revenue: -
Net Income: -

EV

$15M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Almeda Ventures Stock Performance

Almeda Ventures has current market cap of $15M, and enterprise value of $15M.


Almeda Ventures' stock price is $0.79.

See more trading valuation data for Almeda Ventures
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$15M$15M-0.0%----

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Almeda Ventures Valuation Multiples

Almeda Ventures Financial Valuation Multiples

As of October 19, 2026, Almeda Ventures has market cap of $15M and EV of $15M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Almeda Ventures Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Almeda Ventures Competitors

Almeda Ventures competitors include Pardus Girişim, Eurocastle Investment, Spring Ventures, Fuel Ventures, BTC Health, Frontier IP Group, AG Ventures, Netcapital, Scalare Partners Holdings and Hub Girişim.

Most Almeda Ventures public comparables operate across PE & VC.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Pardus Girişim$1M$972K10.1x-13.7x-
Eurocastle Investment$271K-----
Spring Ventures------
Fuel Ventures$516K-28.2x---
BTC Health$68K($414K)190.1x-(31.1x)-
Frontier IP Group$432K($8M)72.8x-(3.7x)-
AG Ventures$11M$1M1.2x-12.0x-
Netcapital$869K($28M)21.5x-(0.7x)-

This data is available for Pro users. Sign up to see all Almeda Ventures competitors and their valuation data.

Start Free Trial

Investments by Almeda Ventures

Almeda Ventures has invested in 5 companies to date.

Latest investment by Almeda Ventures was on June 27th 2023. Almeda Ventures invested in Augmedics in their $83M Series D round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Almeda Ventures

Augmedics
Sensi AI
FlexDex
TailorMed
Description
Augmedics is a Chicago-headquartered medical device company developing augmented reality guidance for spine surgery. Its flagship xvision Spine System projects 3D CT images onto the patient's anatomy in real time through a surgeon-worn AR headset, enhancing precision during pedicle screw placement. Cleared by the FDA in 2021, the technology supports minimally invasive procedures at hospitals across the United States and Europe.
Sensi AI is a Tel Aviv-based provider of audio analytics for security monitoring. Its platform connects to microphones in care facilities and offices to detect anomalies like falls or aggression via sound patterns. Real-time alerts notify staff via mobile apps. Deployed in 50 nursing homes, it analyzes stress indicators and training gaps. Launched in 2021, Sensi integrates with existing CCTV without video recording.
FlexDex is a Brighton, Michigan-headquartered developer of minimally invasive surgical instruments founded in 2010. Its needle driver technology mirrors wrist and elbow motions for laparoscopic procedures, compatible with 5mm trocars. FlexDex holds FDA clearance and supplies hospitals performing gynecologic and general surgeries.
TailorMed is a Boston-headquartered health IT platform that automates financial assistance for patients at over 400 US hospitals. It streamlines co-pay programs, drug replacement, and eligibility screening using AI to reduce bad debt and match patients with aid from pharma manufacturers and foundations.
HQ CountryUnited StatesUnited StatesUnited StatesIsrael
HQ City
Chicago, IL
Austin, TX
-
Tel Aviv
Deal Date27 Jun 202312 Dec 202124 Aug 20217 Jun 2021
RoundSeries DSeries ASeries AUndisclosed stage
Raised$83M$14M$13M$20M
InvestorsRevival Healthcare Capital; H.I.G. Capital; Evidity Health Capital; Almeda Ventures; CPMGSecret Chord Ventures; Jibe Ventures; Matias Ventures; Flint Capital; AltaIR Capital; Almeda Ventures; Entrée Capital; Homeward Ventures; Operator PartnersMINTS; Nirvana Serial Stage Investment Partners; Richard Hylant; Almeda Ventures; Consensus Business Group; Michigan Biomedical Venture Fund; Johnson & Johnson InnovationDiscount Capital; UnityPoint Health Ventures; Allumia Ventures; Bridges Israel; Triventures; Accelmed; Almeda Ventures; Sanara Ventures
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Almeda Ventures investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Almeda Ventures

When was Almeda Ventures founded?Almeda Ventures was founded in 2020.
Where is Almeda Ventures headquartered?Almeda Ventures is headquartered in Israel.
How many employees does Almeda Ventures have?As of today, Almeda Ventures has over 110 employees.
Is Almeda Ventures publicly listed?Yes, Almeda Ventures is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Almeda Ventures?Almeda Ventures trades under AMDA ticker.
When did Almeda Ventures go public?Almeda Ventures went public in 2020.
Who are competitors of Almeda Ventures?Almeda Ventures main competitors include Pardus Girişim, Eurocastle Investment, Spring Ventures, Fuel Ventures, BTC Health, Frontier IP Group, AG Ventures, Netcapital, Scalare Partners Holdings, Hub Girişim.
What is the current market cap of Almeda Ventures?Almeda Ventures' current market cap is $15M.
Is Almeda Ventures profitable?No, Almeda Ventures is not profitable.
How many companies Almeda Ventures has acquired to date?Almeda Ventures hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Almeda Ventures has invested to date?As of October 2026, Almeda Ventures has invested in 5 companies.
What was the last Almeda Ventures investment?On 27th June 2023 Almeda Ventures invested in Augmedics, participating in a $83M Series D round, alongside Revival Healthcare Capital, H.I.G. Capital, Evidity Health Capital, and CPMG.
In what companies Almeda Ventures invested in?Almeda Ventures invested in Augmedics, BioProtect, TailorMed, Sensi AI, and FlexDex.

See public comps similar to Almeda Ventures

Lists including Almeda Ventures

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial